Position in NVAX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$5,479,196
+$5,024,044 QoQ
Shares Held
673,120
+1089.0% QoQ
Ownership
0.408%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Dec 31, 2024CallValue
$0
CallShares
0
PutValue
$525,012
PutShares
65,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jefferies Financial Group Inc. holds $492,279,055 across 85 Biotechnology names. NVAX ranks #21 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
1,354,459 | $92,279,291 | |
| 2 | IMTX |
Immatics N.V.
|
5,059,551 | $49,785,981 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $39,549,742 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
175,599 | $33,196,990 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
468,146 | $26,445,567 | |
| 6 | IMNM |
Immunome Inc.
|
1,160,715 | $25,384,837 | |
| 7 | ARGX |
Argenx SE
|
30,005 | $21,911,151 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
202,410 | $16,986,247 |
All Filings in NVAX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,479,196 | 673,120 | Shares | Defined | 2026-05-08 | |
| 2024-12-31 | $455,152 | 56,611 | Shares | Defined | 2025-02-27 | |
| 2024-12-31 | $525,012 | 65,300 | Put | Defined | 2025-02-27 | |
| 2024-09-30 | $736,467 | 58,311 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $824,739 | 65,300 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $63,300 | 5,000 | Call | Defined | 2024-08-13 | |
| 2024-06-30 | $661,333 | 52,238 | Shares | Defined | 2024-08-13 | |
| 2024-06-30 | $910,254 | 71,900 | Put | Defined | 2024-08-13 | |
| 2024-03-31 | $270,600 | 56,611 | Shares | Defined | 2024-05-13 | |
| 2024-03-31 | $312,134 | 65,300 | Put | Defined | 2024-05-13 | |
| 2023-12-31 | $271,732 | 56,611 | Shares | Defined | 2024-05-06 | |
| 2023-12-31 | $270,240 | 56,300 | Put | Defined | 2024-05-06 | |
| 2023-03-31 | $103,950 | 15,000 | Shares | Defined | 2023-05-15 | |
| 2023-03-31 | $833,679 | 120,300 | Call | Defined | 2023-05-15 | |
| 2022-12-31 | $869,688 | 84,600 | Call | Defined | 2023-09-21 | |
| 2022-12-31 | $275,411 | 26,791 | Shares | Defined | 2023-09-21 | |
| 2022-12-31 | $230,272 | 22,400 | Put | Defined | 2023-09-21 | |
| No filing history on record for this holder in this stock. | ||||||